Sitara Peroxide Past Earnings Performance
Past criteria checks 0/6
Sitara Peroxide's earnings have been declining at an average annual rate of -120.5%, while the Chemicals industry saw earnings growing at 18% annually. Revenues have been declining at an average rate of 64.2% per year.
Key information
-120.5%
Earnings growth rate
-120.4%
EPS growth rate
| Chemicals Industry Growth | 19.3% |
| Revenue growth rate | -64.2% |
| Return on equity | -27.4% |
| Net Margin | -69.7% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Sitara Peroxide makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 720 | -502 | 218 | 0 |
| 31 Dec 22 | 1,084 | -469 | 256 | 0 |
| 30 Sep 22 | 1,607 | -351 | 269 | 0 |
| 30 Jun 22 | 1,743 | -341 | 279 | 0 |
| 31 Mar 22 | 2,014 | -228 | 271 | 0 |
| 31 Dec 21 | 1,978 | -154 | 267 | 0 |
| 30 Sep 21 | 1,746 | -115 | 251 | 0 |
| 30 Jun 21 | 1,865 | 35 | 255 | 0 |
| 31 Mar 21 | 1,745 | 204 | 220 | 0 |
| 31 Dec 20 | 1,745 | 188 | 214 | 0 |
| 30 Sep 20 | 1,921 | 120 | 210 | 0 |
| 30 Jun 20 | 1,745 | 74 | 193 | 0 |
| 31 Mar 20 | 1,906 | -12 | 197 | 0 |
| 31 Dec 19 | 1,917 | 6 | 196 | 0 |
| 30 Sep 19 | 1,877 | 73 | 187 | 0 |
| 30 Jun 19 | 2,036 | 207 | 180 | 0 |
| 31 Mar 19 | 2,042 | 298 | 188 | 0 |
| 31 Dec 18 | 1,889 | 246 | 168 | 0 |
| 30 Sep 18 | 1,627 | 157 | 153 | 0 |
| 30 Jun 18 | 1,322 | -65 | 140 | 0 |
| 31 Mar 18 | 1,108 | -148 | 105 | 0 |
| 31 Dec 17 | 1,078 | -129 | 105 | 0 |
| 30 Sep 17 | 1,119 | -80 | 102 | 0 |
| 30 Jun 17 | 1,060 | -87 | 101 | 0 |
| 31 Mar 17 | 1,053 | -101 | 104 | 0 |
| 31 Dec 16 | 1,098 | -72 | 103 | 0 |
| 30 Sep 16 | 1,168 | -83 | 106 | 0 |
| 30 Jun 16 | 1,310 | 17 | 109 | 0 |
| 31 Mar 16 | 1,377 | 11 | 109 | 0 |
| 31 Dec 15 | 1,371 | -38 | 109 | 0 |
| 30 Sep 15 | 1,334 | -18 | 105 | 0 |
| 30 Jun 15 | 1,325 | -51 | 99 | 0 |
| 31 Mar 15 | 1,293 | -57 | 96 | 0 |
| 31 Dec 14 | 1,336 | -29 | 91 | 0 |
| 30 Sep 14 | 1,410 | -36 | 89 | 0 |
| 30 Jun 14 | 1,426 | 5 | 91 | 0 |
| 31 Mar 14 | 1,419 | 66 | 91 | 0 |
| 31 Dec 13 | 1,297 | 51 | 91 | 0 |
| 30 Sep 13 | 1,226 | 56 | 98 | 0 |
| 30 Jun 13 | 1,110 | -19 | 93 | 0 |
Quality Earnings: SPL is currently unprofitable.
Growing Profit Margin: SPL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if SPL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare SPL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SPL is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (36.4%).
Return on Equity
High ROE: SPL has a negative Return on Equity (-27.41%), as it is currently unprofitable.